Last Modified

• March 20, 2019

Creator

• Braveboy-Wagner, Justin Steven
  • Affiliation: School of Medicine, UNC/NCSU Joint Department of Biomedical Engineering

Abstract

• Thiazolidinediones (TZDs) are believed to exert their antidiabetic effect through a variety of pathways and mechanisms, some of which relate to the toxic properties of these drugs. Research has proven that TZDs impair cell respiration in vitro and that they have an affect on oxidative stress within the cell. This paper investigates the role of mitochondria in rosiglitazone and pioglitazone action with respect to Complexes I and II of the respiratory chain. Inhibition of Complex I was confirmed via the reduced efficiency of mitochondrial respiration at increasing levels of drug concentration, with malate/glutamate as an energizing substrate, and in relation to Complex I (energized by succinate). Additionally, a decrease in the production of extra-mitochondrial reactive oxygen species (ROS) was detected, particularly on exposure to rosiglitazone, possibly correlating with a lower level of cytotoxicity in comparison to pioglitazone.

Date of publication

• December 2009

DOI

• https://doi.org/10.17615/eg7w-qc88

Resource type

• Masters Thesis

Rights statement

• In Copyright

Note

• "... in partial fulfillment of the requirements for the degree of Master of Science in Biomedical Engineering Chapel Hill, North Carolina."

Advisor

• Macdonald, Jeffrey

Language

• English

Publisher

• University of North Carolina at Chapel Hill

Place of publication

• Chapel Hill, NC

Access

• Open access

Parents:

This work has no parents.

Items

Thumbnail	Title	Date Uploaded	Visibility	Actions
	Metabolic effects of rosiglitazone and pioglitazone on Complex I and Complex II respiration in isolated rat mitochondria	2019-04-10	Public	Press to Select an action Download